TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
BIOA

BioAge Labs, Inc

Healthcare · Drug Manufacturers - Specialty & Generic · —

7.90$ -6.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow BIOA
Line item 2013 2014 2015 2016 2017 2022 2023 2024 2025
– – – – – – – – –
– -19.8% +204.4% +120.2% +2.0% -98.6% +25.6% +3.1% +27.5%
– +3.2% -31.1% -25.3% +44.7% -50.9% +18.7% +131.4% +67.5%
– -156.3% – – +260.0% -95.5% +744.0% +66.6% -205.8%
– -100.0% – – – – +61.2% +120.5% +96.4%
– – – – – – +158.3% +37.6% +25,915.3%
– -39.0% -86.3% +131.7% -71.3% – – – –
– – – – – – +1,300.0% -117.1% +0.0%
– -21.3% -30.2% -14.0% -60.1% -86.7% +1,298.2% +991.0% -97.0%
– -155.7% – – -225.5% – – – -150.2%
– – – – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?